ANALYSIS OF THE TYROSINE KINASE DOMAIN OF THE EGFR GENE TO PREDICT RESPONSE TO EGFR TYROSINE KINASE INHIBITORS Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancers (Herbst et al. 2008 New Engl J Med 359:1367-1380). The epidermal growth factor receptor (EGFR) signaling pathway is implicated in tumour cell growth, local invasion, […]
ViewEXCELLING IN SCIENCE & SERVICE